Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 46 of 1714:
36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56
Gene Compound Assay Inh Ic50 Ki View
sodium channel associated protein 2 DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type III, beta DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type I, alpha DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type IX, alpha DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type VII, alpha DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
amiloride-sensitive cation channel 5, intestinal DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type III, beta DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type XI, alpha DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type I, beta DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type 10, alpha polypeptide DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type IV, alpha polypeptide DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type V, alpha polypeptide DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type II, beta DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, nonvoltage-gated 1 alpha DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, nonvoltage-gated 1 gamma DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, nonvoltage-gated 1 beta DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type XI, alpha DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, nonvoltage-gated 1, gamma DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, nonvoltage-gated 1, delta DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
calcium channel, voltage-dependent, beta 1 subunit CLEMASTINE Calcium Channel Type L, Benzothiazepine 78% 2.241uM 1.992uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit CLEMASTINE Calcium Channel Type L, Benzothiazepine 78% 2.241uM 1.992uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit CLEMASTINE Calcium Channel Type L, Benzothiazepine 78% 2.241uM 1.992uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CLEMASTINE Calcium Channel Type L, Benzothiazepine 78% 2.241uM 1.992uM View
androgen receptor GENTIAN VIOLET Testosterone 78% 5.57uM 3.713uM View
thromboxane A synthase 1 GENISTEIN Thromboxane Synthetase 78% 7.72uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) GENISTEIN Thromboxane Synthetase 78% 7.72uM NoneNone View
acetylcholinesterase (YT blood group) GENTIAN VIOLET Acetylcholinesterase 78% 5.847uM NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase GENTIAN VIOLET Acetylcholinesterase 78% 5.847uM NoneNone View
acetylcholinesterase GENTIAN VIOLET Acetylcholinesterase 78% 5.847uM NoneNone View
sodium channel, voltage-gated, type IV, beta BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
sodium channel associated protein 1 BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
sodium channel associated protein 2 BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
sodium channel, voltage-gated, type III, beta BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
sodium channel, voltage-gated, type I, alpha BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
calcium channel, voltage-dependent, alpha 1F subunit BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, beta 1 subunit BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, gamma subunit 8 BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, gamma subunit 7 BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, gamma subunit 6 BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, gamma subunit 5 BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, gamma subunit 4 BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, gamma subunit 3 BENZTROPINE Calcium Channel Type L, Phenylalkylamine 78% 1.348uM 1.311uM View
calcium channel, voltage-dependent, gamma subunit 8 SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, gamma subunit 7 SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, gamma subunit 6 SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, gamma subunit 5 SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, gamma subunit 4 SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, gamma subunit 3 SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, gamma subunit 2 SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, gamma subunit 1 SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, beta 4 subunit SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, beta 3 subunit SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, beta 2 subunit SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, alpha 1F subunit SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, beta 1 subunit SPIRADOLINE Calcium Channel Type L, Phenylalkylamine 78% 5.24uM 5.095uM View
calcium channel, voltage-dependent, gamma subunit 3 PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, gamma subunit 2 PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, gamma subunit 1 PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, beta 4 subunit PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, beta 3 subunit PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, beta 2 subunit PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, alpha 1F subunit PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, beta 1 subunit PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PROMAZINE Calcium Channel Type L, Benzothiazepine 77% 3.217uM 2.86uM View
sodium channel, voltage-gated, type XI, alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type I, beta PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type 10, alpha polypeptide PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type IV, alpha polypeptide PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type V, alpha polypeptide PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type II, beta PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, nonvoltage-gated 1 alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, nonvoltage-gated 1 gamma PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, nonvoltage-gated 1 beta PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type XI, alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, nonvoltage-gated 1, gamma PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, nonvoltage-gated 1, delta PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, nonvoltage-gated 1 alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type X, alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type IX, alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage gated, type VIII, alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type VII, alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type IV, beta PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type IV, alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type III, alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type II, beta PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type II, alpha 2 PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type I, beta PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type I, alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type IV, beta PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel associated protein 1 PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel associated protein 2 PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type III, beta PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type I, alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type IX, alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type VII, alpha PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
amiloride-sensitive cation channel 5, intestinal PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit PAROXETINE Calcium Channel Type L, Phenylalkylamine 76% .747uM .726uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit PAROXETINE Calcium Channel Type L, Phenylalkylamine 76% .747uM .726uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PAROXETINE Calcium Channel Type L, Phenylalkylamine 76% .747uM .726uM View
carbonic anhydrase 5a, mitochondrial ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase 3 ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase 2 ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase 4 ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase XI ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase IX ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase VIII ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase VII ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase VA, mitochondrial ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase IV ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase III, muscle specific ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase I ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase XIV ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase VB, mitochondrial ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase XII ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase VI ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
carbonic anhydrase II ROSIGLITAZONE Carbonic Anhydrase 76% 4.069uM NoneNone View
adrenergic receptor, alpha 1b PROPAFENONE Adrenergic alpha1B 76% 2.558uM 1.416uM View
calcium channel, voltage-dependent, gamma subunit 8 PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, gamma subunit 7 PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, gamma subunit 6 PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, gamma subunit 5 PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, gamma subunit 4 PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, gamma subunit 3 PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, gamma subunit 2 PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, gamma subunit 1 PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, beta 4 subunit PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, beta 3 subunit PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, beta 2 subunit PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, alpha 1F subunit PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, beta 1 subunit PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PENTAMIDINE Calcium Channel Type L, Phenylalkylamine 76% 1.391uM 1.352uM View
calcium channel, voltage-dependent, gamma subunit 8 PERGOLIDE Calcium Channel Type L, Phenylalkylamine 76% .913uM .887uM View
calcium channel, voltage-dependent, gamma subunit 7 PERGOLIDE Calcium Channel Type L, Phenylalkylamine 76% .913uM .887uM View
calcium channel, voltage-dependent, gamma subunit 6 PERGOLIDE Calcium Channel Type L, Phenylalkylamine 76% .913uM .887uM View
calcium channel, voltage-dependent, gamma subunit 5 PERGOLIDE Calcium Channel Type L, Phenylalkylamine 76% .913uM .887uM View
calcium channel, voltage-dependent, gamma subunit 4 PERGOLIDE Calcium Channel Type L, Phenylalkylamine 76% .913uM .887uM View
calcium channel, voltage-dependent, gamma subunit 3 PERGOLIDE Calcium Channel Type L, Phenylalkylamine 76% .913uM .887uM View
calcium channel, voltage-dependent, gamma subunit 2 PERGOLIDE Calcium Channel Type L, Phenylalkylamine 76% .913uM .887uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 BW-723C86 Dopamine Transporter 76% 2.6846uM 2.133uM View
dopamine receptor D3 TRANS-PLATINUM(II)DIAMMINE DICHLORIDE Dopamine D3 76% 3.3237uM 1.1288uM View
cholinergic receptor, muscarinic 3 PERHEXILINE Muscarinic M3 76% 3.1186uM .661uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, nonvoltage-gated 1 alpha DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type X, alpha DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage-gated, type IX, alpha DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
sodium channel, voltage gated, type VIII, alpha DOXORUBICIN Sodium Channel, Site 2 75% 15.245uM 13.668uM View
5-hydroxytryptamine receptor 6 AMLODIPINE Serotonin 5-HT6 75% 2.898uM 1.346uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 LOVASTATIN Adrenergic, Norepinephrine Transporter 75% 8.753uM 8.68uM View
opioid receptor, delta 1 AMIODARONE Opiate delta 75% 8.014uM 2.825uM View
5-hydroxytryptamine (serotonin) receptor 3a CHLORPROMAZINE Serotonin 5-HT3 75% 7.365uM 1.655uM View
5-hydroxytryptamine (serotonin) receptor 3b CHLORPROMAZINE Serotonin 5-HT3 75% 7.365uM 1.655uM View
aldo-keto reductase family 1, member B4 (aldose reductase) ZOMEPIRAC Aldose Reductase 75% 1.29uM NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) ZOMEPIRAC Aldose Reductase 75% 1.29uM NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) ZOMEPIRAC Aldose Reductase 75% 1.29uM NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) ZOMEPIRAC Aldose Reductase 75% 1.29uM NoneNone View
melanocortin 5 receptor TAMOXIFEN Melanocortin MC5 75% 26.529uM 24.886uM View
bradykinin receptor, beta 2 TAMOXIFEN Bradykinin B2 75% 20.356uM 12.048uM View
bradykinin receptor B2 TAMOXIFEN Bradykinin B2 75% 20.356uM 12.048uM View
progesterone receptor TAMOXIFEN Progesterone 75% 19.846uM 2.589uM View
progesterone receptor TAMOXIFEN Progesterone 75% 19.846uM 2.589uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 THIMEROSAL Serotonin Transporter 75% 2.015uM 1.07uM View
phosphodiesterase 5A, cGMP-specific DIPYRIDAMOLE Phosphodiesterase PDE5 75% 2.831uM NoneNone View
phosphodiesterase 5A, cGMP-specific DIPYRIDAMOLE Phosphodiesterase PDE5 75% 2.831uM NoneNone View
prostaglandin-endoperoxide synthase 1 IPRIFLAVONE Cyclooxygenase COX-1 75% 2.9443uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) IPRIFLAVONE Cyclooxygenase COX-1 75% 2.9443uM NoneNone View
aldo-keto reductase family 1, member B4 (aldose reductase) DICUMAROL Aldose Reductase 75% 4.093uM NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) DICUMAROL Aldose Reductase 75% 4.093uM NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) DICUMAROL Aldose Reductase 75% 4.093uM NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) DICUMAROL Aldose Reductase 75% 4.093uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B TOLNAFTATE Serotonin 5-HT2B 75% 2.007uM 1.277uM View
adrenergic receptor, alpha 2b MOSAPRIDE Adrenergic alpha2B 75% 1.908uM .871uM View
mitogen activated protein kinase 14 ISOTRETINOIN Protein Serine/Threonine Kinase, p38alpha 75% 2.529uM NoneNone View
mitogen-activated protein kinase 14 ISOTRETINOIN Protein Serine/Threonine Kinase, p38alpha 75% 2.529uM NoneNone View